Literature DB >> 8811766

Use of hormone replacement therapy. Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive.

K Mckinney.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8811766      PMCID： PMC2352007          DOI： 10.1136/bmj.313.7058.686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Women need to be fully informed about risks of hormone replacement therapy.

Authors:  E H Price; H K Little
Journal:  BMJ       Date:  1996-05-18

2.  The risk of breast cancer after estrogen and estrogen-progestin replacement.

Authors:  L Bergkvist; H O Adami; I Persson; R Hoover; C Schairer
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

3.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

4.  The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy.

Authors:  P A Wingo; P M Layde; N C Lee; G Rubin; H W Ory
Journal:  JAMA       Date:  1987-01-09       Impact factor: 56.272
  4 in total
  1 in total

1.  Hormone replacement therapy for all? Long-term randomised controlled trial is needed.

Authors:  R Lyons
Journal:  BMJ       Date:  1996-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.